ELUTIA INC. (ELUT)

↓ Download CSV

CIK 0001708527 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, ELUTIA INC. reported revenue of $12.29M, down 15.0% from the prior year. The company was profitable, with a net margin of 434.2% and a gross margin of 53.7%. It held $62.35M in total assets against $34.68M in total liabilities.

Key ratios (FY2025)

53.7%
Gross margin
-218.9%
Operating margin
434.2%
Net margin
192.9%
Return on equity
-15.0%
Revenue growth (YoY)
Metric (FY)20252024202320222021202020192018
Revenue$12.29M$14.47M$24.75M$23.85M$47.39M$42.68M$42.90M
Cost of Revenue$5.70M$7.75M$13.69M$12.21M$28.37M$22.12M$23.13M
Gross Profit$6.60M$6.71M$11.05M$11.64M$19.02M$20.56M$19.77M
Operating Income-$26.91M-$30.71M-$30.53M-$35.19M-$23.03M-$13.60M-$8.41M
Net Income$53.38M-$53.95M-$37.66M-$32.90M-$24.83M-$21.82M-$11.94M
EPS (Diluted)$0.87$-1.86$-2.07$-2.38$-2.38$-8.88
Total Assets$62.35M$36.13M$43.43M$68.84M$67.17M$82.81M$44.77M
Total Liabilities$34.68M$82.39M$82.03M$73.87M$53.65M$61.98M$55.43M
Shareholders' Equity$27.67M-$46.26M-$38.60M-$5.03M$13.52M$20.83M-$55.11M-$43.41M
Cash & Equivalents$36.35M$13.24M$19.28M$16.99M$30.39M$39.15M$2.48M
Operating Cash Flow-$44.81M-$22.66M-$21.76M-$21.43M-$15.45M-$13.63M-$7.22M
Capital Expenditures$1.88M$654.0K$346.0K$540.0K$369.0K$640.0K$577.0K
Shares Outstanding45.94M29.07M18.16M13.83M10.44M2.85M